ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal Cancer

NCT00026364 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

NIH

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: fluorouracil
DRUG: gefitinib
DRUG: irinotecan hydrochloride
DRUG: leucovorin calcium

Sponsor

National Cancer Institute (NCI)